Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex
This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incuba...
Gespeichert in:
Veröffentlicht in: | Experimental parasitology 2005-09, Vol.111 (1), p.47-54 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 54 |
---|---|
container_issue | 1 |
container_start_page | 47 |
container_title | Experimental parasitology |
container_volume | 111 |
creator | AL-MULLA HUMMADI, Yassir M NAJIM, Rafid A AL-BASHIR, Nada M |
description | This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incubated with different concentrations of S2-Complex. The EC50 for each form was calculated. Results show that all forms of the parasites were dose dependently inhibited by S2-Complex. The promastigotes of both parasites were the most resistant with highest EC50 followed by axenic amastigotes. While intracellular amastigotes were the most sensitive with the lowest EC50. These results indicate that S2-Complex has a direct anti-leishmanial effect. When mice were treated with S2-Complex or BCG for four days before harvesting the macrophages, and the macrophages infected with both L. major and L. tropica, they showed increased phagocytosis and increased parasite killing. The results of S2-Complex were not statistically different from the immunomodulating agent BCG. These results indicate that S2-Complex has an immunomodulating effect in addition to the direct anti-leishmanial effect. |
doi_str_mv | 10.1016/j.exppara.2005.04.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68427606</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68427606</sourcerecordid><originalsourceid>FETCH-LOGICAL-c252t-7368e1f87de738f9e9a9a5f1177b50e681739d4014cd5c01e2f823f93ea25c403</originalsourceid><addsrcrecordid>eNpNkF2L1TAQhoMo7nH1Jyi50StbJ2nSJN7JwY-FA16o1yEnnbA5NE1NWln_vV22sF4NvDzvDPMQ8ppBy4D1Hy4t3s2zK67lALIF0QKoJ-TAwEDDhTBPyQGAiUZoI67Ii1ovAKAZF8_JFZNGAdf9gZxPGOttclN0NLlLLtRNA_0vXEqeo3f0I72hyy3SONE_cQsphoB-qTSHrUJjSuuUUx7W0S25vKc_eHPMaR7x7iV5FtxY8dU-r8mvL59_Hr81p-9fb46fTo3nki-N6nqNLGg1oOp0MGiccTIwptRZAvaaqc4MYnvJD9IDQx4074Lp0HHpBXTX5N3D3rnk3yvWxaZYPY6jmzCv1fZacNVDv4HyAfQl11ow2LnE5Mpfy8Dey7UXu8u193ItCLvJ3Xpv9gPrOeHw2NptbsDbHXDVuzEUN_lYHzkFnQTOu393T4Qw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68427606</pqid></control><display><type>article</type><title>Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>AL-MULLA HUMMADI, Yassir M ; NAJIM, Rafid A ; AL-BASHIR, Nada M</creator><creatorcontrib>AL-MULLA HUMMADI, Yassir M ; NAJIM, Rafid A ; AL-BASHIR, Nada M</creatorcontrib><description>This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incubated with different concentrations of S2-Complex. The EC50 for each form was calculated. Results show that all forms of the parasites were dose dependently inhibited by S2-Complex. The promastigotes of both parasites were the most resistant with highest EC50 followed by axenic amastigotes. While intracellular amastigotes were the most sensitive with the lowest EC50. These results indicate that S2-Complex has a direct anti-leishmanial effect. When mice were treated with S2-Complex or BCG for four days before harvesting the macrophages, and the macrophages infected with both L. major and L. tropica, they showed increased phagocytosis and increased parasite killing. The results of S2-Complex were not statistically different from the immunomodulating agent BCG. These results indicate that S2-Complex has an immunomodulating effect in addition to the direct anti-leishmanial effect.</description><identifier>ISSN: 0014-4894</identifier><identifier>EISSN: 1090-2449</identifier><identifier>DOI: 10.1016/j.exppara.2005.04.007</identifier><identifier>PMID: 15970286</identifier><identifier>CODEN: EXPAAA</identifier><language>eng</language><publisher>San Diego, CA: Elsevier</publisher><subject><![CDATA[Animals ; Ascorbic Acid - administration & dosage ; Ascorbic Acid - pharmacology ; BCG Vaccine - administration & dosage ; BCG Vaccine - immunology ; BCG Vaccine - pharmacology ; Biological and medical sciences ; Copper - administration & dosage ; Copper - pharmacology ; Culture Media ; Drug Combinations ; Fundamental and applied biological sciences. Psychology ; Immunologic Factors - administration & dosage ; Immunologic Factors - pharmacology ; Injections, Intraperitoneal ; Leishmania major - drug effects ; Leishmania tropica - drug effects ; Life cycle. Host-agent relationship. Pathogenesis ; Macrophages, Peritoneal - drug effects ; Mice ; Mice, Inbred BALB C ; Niacinamide - administration & dosage ; Niacinamide - pharmacology ; Protozoa ; Starch - administration & dosage]]></subject><ispartof>Experimental parasitology, 2005-09, Vol.111 (1), p.47-54</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c252t-7368e1f87de738f9e9a9a5f1177b50e681739d4014cd5c01e2f823f93ea25c403</citedby><cites>FETCH-LOGICAL-c252t-7368e1f87de738f9e9a9a5f1177b50e681739d4014cd5c01e2f823f93ea25c403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17035022$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15970286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AL-MULLA HUMMADI, Yassir M</creatorcontrib><creatorcontrib>NAJIM, Rafid A</creatorcontrib><creatorcontrib>AL-BASHIR, Nada M</creatorcontrib><title>Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex</title><title>Experimental parasitology</title><addtitle>Exp Parasitol</addtitle><description>This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incubated with different concentrations of S2-Complex. The EC50 for each form was calculated. Results show that all forms of the parasites were dose dependently inhibited by S2-Complex. The promastigotes of both parasites were the most resistant with highest EC50 followed by axenic amastigotes. While intracellular amastigotes were the most sensitive with the lowest EC50. These results indicate that S2-Complex has a direct anti-leishmanial effect. When mice were treated with S2-Complex or BCG for four days before harvesting the macrophages, and the macrophages infected with both L. major and L. tropica, they showed increased phagocytosis and increased parasite killing. The results of S2-Complex were not statistically different from the immunomodulating agent BCG. These results indicate that S2-Complex has an immunomodulating effect in addition to the direct anti-leishmanial effect.</description><subject>Animals</subject><subject>Ascorbic Acid - administration & dosage</subject><subject>Ascorbic Acid - pharmacology</subject><subject>BCG Vaccine - administration & dosage</subject><subject>BCG Vaccine - immunology</subject><subject>BCG Vaccine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Copper - administration & dosage</subject><subject>Copper - pharmacology</subject><subject>Culture Media</subject><subject>Drug Combinations</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Immunologic Factors - administration & dosage</subject><subject>Immunologic Factors - pharmacology</subject><subject>Injections, Intraperitoneal</subject><subject>Leishmania major - drug effects</subject><subject>Leishmania tropica - drug effects</subject><subject>Life cycle. Host-agent relationship. Pathogenesis</subject><subject>Macrophages, Peritoneal - drug effects</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Niacinamide - administration & dosage</subject><subject>Niacinamide - pharmacology</subject><subject>Protozoa</subject><subject>Starch - administration & dosage</subject><issn>0014-4894</issn><issn>1090-2449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkF2L1TAQhoMo7nH1Jyi50StbJ2nSJN7JwY-FA16o1yEnnbA5NE1NWln_vV22sF4NvDzvDPMQ8ppBy4D1Hy4t3s2zK67lALIF0QKoJ-TAwEDDhTBPyQGAiUZoI67Ii1ovAKAZF8_JFZNGAdf9gZxPGOttclN0NLlLLtRNA_0vXEqeo3f0I72hyy3SONE_cQsphoB-qTSHrUJjSuuUUx7W0S25vKc_eHPMaR7x7iV5FtxY8dU-r8mvL59_Hr81p-9fb46fTo3nki-N6nqNLGg1oOp0MGiccTIwptRZAvaaqc4MYnvJD9IDQx4074Lp0HHpBXTX5N3D3rnk3yvWxaZYPY6jmzCv1fZacNVDv4HyAfQl11ow2LnE5Mpfy8Dey7UXu8u193ItCLvJ3Xpv9gPrOeHw2NptbsDbHXDVuzEUN_lYHzkFnQTOu393T4Qw</recordid><startdate>200509</startdate><enddate>200509</enddate><creator>AL-MULLA HUMMADI, Yassir M</creator><creator>NAJIM, Rafid A</creator><creator>AL-BASHIR, Nada M</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200509</creationdate><title>Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex</title><author>AL-MULLA HUMMADI, Yassir M ; NAJIM, Rafid A ; AL-BASHIR, Nada M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c252t-7368e1f87de738f9e9a9a5f1177b50e681739d4014cd5c01e2f823f93ea25c403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Ascorbic Acid - administration & dosage</topic><topic>Ascorbic Acid - pharmacology</topic><topic>BCG Vaccine - administration & dosage</topic><topic>BCG Vaccine - immunology</topic><topic>BCG Vaccine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Copper - administration & dosage</topic><topic>Copper - pharmacology</topic><topic>Culture Media</topic><topic>Drug Combinations</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Immunologic Factors - administration & dosage</topic><topic>Immunologic Factors - pharmacology</topic><topic>Injections, Intraperitoneal</topic><topic>Leishmania major - drug effects</topic><topic>Leishmania tropica - drug effects</topic><topic>Life cycle. Host-agent relationship. Pathogenesis</topic><topic>Macrophages, Peritoneal - drug effects</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Niacinamide - administration & dosage</topic><topic>Niacinamide - pharmacology</topic><topic>Protozoa</topic><topic>Starch - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AL-MULLA HUMMADI, Yassir M</creatorcontrib><creatorcontrib>NAJIM, Rafid A</creatorcontrib><creatorcontrib>AL-BASHIR, Nada M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AL-MULLA HUMMADI, Yassir M</au><au>NAJIM, Rafid A</au><au>AL-BASHIR, Nada M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex</atitle><jtitle>Experimental parasitology</jtitle><addtitle>Exp Parasitol</addtitle><date>2005-09</date><risdate>2005</risdate><volume>111</volume><issue>1</issue><spage>47</spage><epage>54</epage><pages>47-54</pages><issn>0014-4894</issn><eissn>1090-2449</eissn><coden>EXPAAA</coden><abstract>This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incubated with different concentrations of S2-Complex. The EC50 for each form was calculated. Results show that all forms of the parasites were dose dependently inhibited by S2-Complex. The promastigotes of both parasites were the most resistant with highest EC50 followed by axenic amastigotes. While intracellular amastigotes were the most sensitive with the lowest EC50. These results indicate that S2-Complex has a direct anti-leishmanial effect. When mice were treated with S2-Complex or BCG for four days before harvesting the macrophages, and the macrophages infected with both L. major and L. tropica, they showed increased phagocytosis and increased parasite killing. The results of S2-Complex were not statistically different from the immunomodulating agent BCG. These results indicate that S2-Complex has an immunomodulating effect in addition to the direct anti-leishmanial effect.</abstract><cop>San Diego, CA</cop><pub>Elsevier</pub><pmid>15970286</pmid><doi>10.1016/j.exppara.2005.04.007</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4894 |
ispartof | Experimental parasitology, 2005-09, Vol.111 (1), p.47-54 |
issn | 0014-4894 1090-2449 |
language | eng |
recordid | cdi_proquest_miscellaneous_68427606 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Animals Ascorbic Acid - administration & dosage Ascorbic Acid - pharmacology BCG Vaccine - administration & dosage BCG Vaccine - immunology BCG Vaccine - pharmacology Biological and medical sciences Copper - administration & dosage Copper - pharmacology Culture Media Drug Combinations Fundamental and applied biological sciences. Psychology Immunologic Factors - administration & dosage Immunologic Factors - pharmacology Injections, Intraperitoneal Leishmania major - drug effects Leishmania tropica - drug effects Life cycle. Host-agent relationship. Pathogenesis Macrophages, Peritoneal - drug effects Mice Mice, Inbred BALB C Niacinamide - administration & dosage Niacinamide - pharmacology Protozoa Starch - administration & dosage |
title | Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T10%3A19%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leishmania%20major%20and%20Leishmania%20tropica%20:%20I%20the%20in%20vitro%20effects%20of%20an%20immunomodulator,%20S2-Complex&rft.jtitle=Experimental%20parasitology&rft.au=AL-MULLA%20HUMMADI,%20Yassir%20M&rft.date=2005-09&rft.volume=111&rft.issue=1&rft.spage=47&rft.epage=54&rft.pages=47-54&rft.issn=0014-4894&rft.eissn=1090-2449&rft.coden=EXPAAA&rft_id=info:doi/10.1016/j.exppara.2005.04.007&rft_dat=%3Cproquest_cross%3E68427606%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68427606&rft_id=info:pmid/15970286&rfr_iscdi=true |